Ferrari Mauro
SEC Form 4 insider trading activity
Ferrari Mauro has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Dec 30, 2025.
On the most recent filing, Ferrari Mauro is listed as Director at ARROWHEAD PHARMACEUTICALS, INC. Inside the rolling window, Ferrari Mauro reported no open-market purchases and 2 open-market sales totaling $1.0M in ARWR. The largest disclosed transaction in the window is a sale of 7,530 ARWR shares on Dec 26, 2025, worth $527K.
Companies traded
Other insiders at ARWR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.0M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Ferrari Mauro made?
Ferrari Mauro has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does Ferrari Mauro trade?
Ferrari Mauro has filed SEC Form 4 disclosures for 1 company, including ARWR.
When was Ferrari Mauro's most recent SEC Form 4 filing?
Ferrari Mauro's most recent SEC Form 4 filing on Tracefour is dated Dec 30, 2025.
What is Ferrari Mauro's total buy and sell value in the current window?
Inside the rolling retention window, Ferrari Mauro bought $0 and sold $1.0M based on SEC Form 4 filings.
What was Ferrari Mauro's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 7,530 ARWR shares on 2025-12-26, worth $527K, per SEC Form 4 filings.